Genetic Testing For Breast Cancer

Featured Article

The U.S. Food and Drug Administration has approved a genetic test that can determine if women with breast cancer will be helped by the drug Herceptin. The SPOT-Light HER2 CISH kit determines how many copies of the HER2 gene are in tumor tissue. Women who have more than two copies of the gene may be helped by taking Herceptin, a common drug that helps stop the overproduction of cancer cells. The new test also allows labs to store tumor tissue for future evaluation.

Read more

More information on "Genetic Testing For Breast Cancer"

From Our Experts

See more SharePosts »

From Our Sources

More on Breast Cancer »